Sector revisions Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart 15:55:58 2026-08-12 EDT			5-day change	1st Jan Change
0.1800 ^EUR	0.00%		+38.46%	-12.62%

08-06	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI
07-08	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	WUXI APPTEC CO., LTD.							18
	ARGENX SE							15
	INSMED INCORPORATED							22
	WUXI BIOLOGICS (CAYMAN) INC.							22
	BIONTECH SE							20
	PHARMAESSENTIA CORPORATION							7
	GENMAB A/S							15
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							17
	EXELIXIS, INC.							16
	ARROWHEAD PHARMACEUTICALS, INC.							11
	MADRIGAL PHARMACEUTICALS, INC.							16
	SUMMIT THERAPEUTICS INC.							13
	AKESO, INC.							20
	CYTOKINETICS, INCORPORATED							20
	REMEGEN CO., LTD.							15
	CRINETICS PHARMACEUTICALS, INC.							10
	VAXCYTE, INC.							9
	IMMUNITYBIO, INC.							4
	Average							15
	Weighted average by Cap.							16